41/2026・Trifork Group announces partial divestment of Trifork Labs portfolio assets to Verdane, and proposes an extraordinary dividend of DKK 3.00 per share, subject to transaction completion
Summary
Trifork Group agreed to sell part of its Trifork Labs portfolio to Verdane for EUR 22.8 million in cash plus potential earnout payments. The transaction covers stakes in Axoniq, Dawn Health, Frameo, and XCI, while Trifork keeps some upside exposure in several holdings. Trifork also proposed an extraordinary dividend of DKK 3.00 per share, subject to closing and shareholder approval. After the deal, Trifork plans to move other minority investments into a new vehicle called LabsX and pursue additional exits over the next 24 months.
Classifications
industries
Fintech & Banking
applications
Web and Content Management
AskAI Classifications
Labels
SaaS
Artificial Intelligence Software
Enterprise Software
